Vanguard Information Technology Index Fund ETF (VGT) Stock Price Today
Aura AI Summary
Key Stats
- -Market Cap
- -Volume
- -Sector
- $125.7752W High
- $83.5952W Low
- -Typical Hold Time
- -Enterprise Value
- -Div Yield
- -Trading Activity
Track Vanguard Information Technology Index Fund ETF (VGT) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Vanguard Information Technology Index Fund ETF has traded between a low of $83.59 and a high of $125.77, highlighting its annual price range. Buy and sell Vanguard Information Technology Index Fund ETF shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.
About Vanguard Information Technology Index Fund ETF
The fund employs an indexing investment approach designed to track the performance of the MSCI US Investable Market Index/Information Technology 25/50, an index made up of stocks of large, mid-size, and small US companies within the information technology sector, as classified under the GICS. The advisor attempts to replicate the target index by seeking to invest all of its assets in the stocks that make up the index, in order to hold each stock in approximately the same proportion as its weighting in the index. It is non-diversified.
Most Recent News
KKR gets Buy rating amid $17B USI sale and $250M DOJ fine, signaling mixed but positive outlook
KKR received a Buy rating from UBS as it sells USI Insurance Services to Aon for $17 billion, marking a major strategic move. Despite facing a record $250 million penalty from the Justice Department over premerger rules, analysts see potential positi...
Apple shares rise 2.7% as John Ternus takes over as CEO, succeeding Tim Cook.
John Ternus officially became Apple's CEO, succeeding Tim Cook, causing shares to rise 2.7%. Ternus, previously senior VP of hardware engineering, praised Cook's leadership and expressed excitement about upcoming product launches and innovations. Ana...
FDA warns against unapproved compounded weight-loss drugs, shares of Hims & Hers drop 3.2%.
The FDA issued warnings to telehealth companies and compounding pharmacies about the use of unapproved compounded weight-loss drugs, including versions of semaglutide, tirzepatide, and retatrutide. Hims & Hers Health shares fell 3.2% following the an...
People also bought
Frequently Asked Questions
All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.